The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Laforce James since year 2005.
The trader's CIK number is 1075514.
At the time of the last reporting, Laforce James was the Director of Arena Pharmaceuticals Inc .
(stock ticker symbol ARNA).
See this page for all insider trading activities at Arena Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2009-05-14||ARNA||Arena Pharmaceuticals Inc||Buy||3,500||2.74||9,590|
|2008-05-13||ARNA||Arena Pharmaceuticals Inc||Buy||10,000||5.18||51,800|
|2005-12-09||BWC||Blackrock World Investment Trust||Buy||250||14.70||3,675|
|2005-12-09||BDJ||Blackrock Enhanced Equity Dividend Trust||Buy||600||13.03||7,818|
|2005-06-23||HIS||Blackrock High Income Shares||Buy||200||2.83||566|
|2005-06-23||BOE||Blackrock Enhanced Global Dividend Trust||Buy||200||25.01||5,002|
|2005-04-22||BME||Blackrock Health Sciences Trust||Buy||150||25.02||3,753|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laforce James (Director of Arena Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.